Table 4.
Characteristics | Unadjusted | Model 1 | Model 2 |
---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Age (years) | 1.04 (1.02–1.05) | 1.02 (1.01–1.03) | 1.02 (1.01–1.03) |
Gender (Male) | 1.09 (0.83–1.43) | 5.62 (3.62–8.71) | 5.56 (3.53–8.74) |
Loss of appetite | 2.37 (1.79–3.12) | 2.50 (1.75–3.58) | 2.50 (1.73–3.62) |
Dysgeusia | 3.47 (2.59–4.65) | 3.81 (2.19–6.64) | 4.05 (2.30–7.21) |
Myalgia | 1.34 (1.01–1.78) | 1.04 (0.66–1.65) | 0.98 (0.61–1.56) |
Joint pain | 1.34 (1.01–1.78) | 1.17 (0.75–1.82) | 1.26 (0.80–1.98) |
Smell disorders | 2.50 (1.88–3.31) | 0.91 (0.52–1.59) | 0.84 (0.48–1.48) |
Headache | 1.30 (0.99–1.71) | 1.09 (0.73–1.61) | 1.12 (0.75–1.67) |
Skin lesion | 1.52 (1.03–2.25) | 1.29 (0.77–2.16) | 1.20 (0.70–2.03) |
Severity of COVID-19 | |||
Home | 1.0 (Reference) | 1.0 (Reference) | |
Hospital-no O2 support | 0.77 (0.48–1.26) | 0.93 (0.51–1.70) | |
Hospital-O2 support | 0.60 (0.42–1.03) | 0.73 (0.43–1.23) | |
Hospital-high-flow O2 | 0.99 (0.56–1.78) | 1.01 (0.57–1.80) | |
Hospital-Invasive Ventilation | 1.05 (0.87–2.38) | 1.95 (0.87–4.38) |
CI confidence interval, OR Odds ratio